Skip to main navigation Skip to search Skip to main content

Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy

  • Wendy L. Allen
  • , Philip D. Dunne
  • , Simon McDade
  • , Enya Scanlon
  • , Maurice Loughrey
  • , Helen G. Coleman
  • , Christopher McCann
  • , Kristy McLaughlin
  • , Zsuzsanna Nemeth
  • , Najeeb Ashraf Syed
  • , Puthen Veettil Jithesh
  • , Ken Arthur
  • , Richard Wilson
  • , Vicky M. Coyle
  • , Darragh McArt
  • , Graeme I. Murray
  • , Leslie Samuel
  • , Paolo Nuciforo
  • , Jose Jimenez
  • , Guillem Argiles
    • Rodrigo Dienstmann, Josef Tabernero, Lucia Picariello, Luca Messerini, Stefania Nobili, Enrico Mini, Kieran Sheahan, Elizabeth Ryan, Patrick G. Johnston, Sandra Van Schaeybroeck, Mark Lawler, Daniel B. Longley
  • Queen's University Belfast
  • Sidra Medical and Research Center
  • NHS Grampian
  • Vall d'Hebron University Hospital
  • University of Florence
  • University College Dublin

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology